Sinopia Biosciences

Sinopia Biosciences leverages computational biology and AI/ML techniques to accelerate drug discovery and the development of therapies for complex diseases, with an initial focus on Parkinson’s disease. Their proprietary platform uses deep learning to analyze biological and omics data, enabling the identification of novel drug targets and therapeutic opportunities for brain health. This tool is aimed at pharmaceutical companies, biomedical researchers, and life sciences organizations interested in AI-driven drug discovery and therapeutic innovation.